Fecal Biomarkers to Characterize Intestinal Inflammation among Children with Medically Attended Diarrhea across Six Low-Resource Settings: Findings from the Enterics for Global Health (EFGH) Shigella Surveillance Study
Year: 2026
Type: preprint
Study design: Observational Study
Abstract: ABSTRACT Background Frequent enteric infections can damage the small intestine causing inflammation and malabsorption, leading to environmental enteric dysfunction. We aimed to characterize the association between intestinal inflammation and enteric pathogens among children in low- and middle-income countries (LMICs) who presented to care with diarrhea. Methodology/Principle Findings We conducted a cross-sectional analysis within the Enterics for Global Health - Shigella Surveillance Study at six LMIC sites: Bangladesh, Kenya, Malawi, Pakistan, Peru, and The Gambia. From August 2022 to July 2024, rectal swabs and whole stool samples were collected from 4,903 children with medically attended diarrhea aged 6-35 months (44.4% females, n=2178/4903; mean age: 15.4 months ± 7.4 months) and were analyzed for Shigella and four fecal inflammatory biomarkers: hemoglobin, lipocalin-2, myeloperoxidase, and calprotectin via Enzyme Linked Immunosorbent Assays. Caregivers and clinicians demonstrated moderate accuracy in identifying blood in stool compared to fecal hemoglobin (area under the curve (AUC)=0.70). Among 10 pathogens evaluated, Shigella -attributable diarrhea had the highest concentrations of calprotectin, hemoglobin, and myeloperoxidase. Shigella culture-/PCR+ episodes had intermediate levels of inflammation between culture-/PCR- and culture+ episodes. In multivariable models restricted to Shigella episodes, dysentery was positively associated and vomiting was negatively associated with biomarker concentrations, with the strongest associations observed for hemoglobin (dysentery geometric mean ratio: 14.91 μg/g (95% CI: 8.77, 25.36) and vomiting geometric mean ratio: 0.44 μg/g (95% CI: 0.24, 0.81)). Age, sex, and both acute and chronic malnutrition were not associated with inflammatory biomarker concentrations. Conclusions/Significance Hemoglobin appeared to be a more sensitive marker of blood in stool than visual observation. While Shigella was associated with heightened levels of all inflammatory biomarkers, hemoglobin was most strongly associated with Shigella , especially among attributable and culture positive episodes. The distinct clinical characteristics of Shigella were most closely associated with elevated hemoglobin concentrations, suggesting its potential utility as a point-of-care diagnostic. AUTHOR SUMMARY Diarrhea is common among children under five years of age in low- and middle-income countries (LMICs). Repeated diarrheal illnesses can damage the gut, leading to issues with growth and brain development. We examined fecal samples collected from 4,903 children with diarrhea who were enrolled in the Enterics for Global Health - Shigella Surveillance Study. We tested samples for diarrheal pathogens and measured four inflammatory biomarkers. We found that hemoglobin better identified blood in stool than visual observation of blood. Additionally, certain biomarkers (calprotectin, myeloperoxidase, and most notably hemoglobin) were higher when diarrhea was caused by bacteria such as Shigella than when diarrhea was caused by viruses. Also, we discovered that Shigella episodes identified using molecular diagnostics caused a similar illness as those identified by culture. These results support that Shigella diarrhea episodes identified by molecular diagnostics or culture are more inflammatory than other episodes of diarrhea and may require appropriate antibiotic treatment.
Source: medRxiv
Authors: Bri’Anna Horne, Brian Otieno Onyando, Henry Badji, Wardah Mujahid, Taufiqur Rahman Bhuiyan, Mutsai Bakali, Junaid Iqbal, Maribel Paredes Olortegui, Patricia Pavlinac, Bubacarr E. Ceesay, Olivia Schultes, Sharon M. Tennant, Billy Ogwel, Desiree Witte, Hannah Atlas, Naveed Ahmed, John Benjamin Ochieng, Khandra Sears, Sadia Islam, Queen Saidi, Samba Juma Jallow, Zarfishan Hussain, Paul Garcia Bardales, James A. Platts-Mills, Richard Omore, Farhana Khanam, Md. Parvej Mosharraf, Ousman Secka, Vitumbiko Munthali, Margaret N Kosek, Maureen Ndalama, Jen Cornick, Mohammad Tahir Yousafzai, M. Jahangir Hossain, Catherine Sonye, Firdausi Qadri, Elizabeth T. Rogawski McQuade, Stephanie A. Brennhofer
Institutions: University of Maryland, Baltimore, Kenya Medical Research Institute, MRC Unit the Gambia, Aga Khan University, International Centre for Diarrhoeal Disease Research, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Prisma, University of Washington, University of Liverpool, Baltimore City Community College, University of Virginia, UNSW Sydney, Emory University
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: University of Virginia - to provide technical support to the EFGH shigella burden study and Global Pediatric Diarrhea Surveillance platform at WHO, that will improve our es..., Emory University - to develop in principle and assess the feasibility of a low-cost point of care test for diarrhea caused by bacterial pathogens based on inflammator..., University of Virginia - to conduct serologic studies on dried blood spots from children presenting with shigellosis to better understand immunity to Shigella and help conf..., University of Virginia - to provide technical support for molecular diagnostic approaches for shigella detection across multiple settings, Aga Khan University - to conduct a Shigella surveillance study in Pakistan to support the clinical development of vaccines against shigellosis, University of Washington Foundation - to conduct a multi-center Shigella surveillance study to support the clinical development of vaccines against shigellosis, University of Washington Foundation - to support a multi-center Shigella surveillance study to support the clinical development of vaccines against shigellosis, International Centre for Diarrhoeal Disease Research, Bangladesh - to conduct a Shigella surveillance study in Bangladesh to support the clinical development of vaccines against shigellosis
OpenAlex ID: W7160320100
